Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
68,154,863
-
Shares change
-
+1,124,706
-
Total reported value, excl. options
-
$1,102,711,080
-
Value change
-
-$36,197,720
-
Put/Call ratio
-
89.05%
-
Number of buys
-
68
-
Number of sells
-
-79
-
Price
-
$16.18
Significant Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q1 2021
177 filings reported holding MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68,154,863 shares
.
Largest 10 shareholders include BlackRock Inc. (8,002,086 shares), Avoro Capital Advisors LLC (6,800,000 shares), WELLINGTON MANAGEMENT GROUP LLP (6,177,793 shares), Sarissa Capital Management LP (4,005,600 shares), STATE STREET CORP (3,746,000 shares), Bain Capital Life Sciences Investors, LLC (3,695,667 shares), VANGUARD GROUP INC (3,117,369 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,974,087 shares), Bellevue Group AG (2,850,010 shares), and Rock Springs Capital Management LP (2,775,127 shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.